These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


272 related items for PubMed ID: 8050478

  • 1. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
    Madras BK, Reith ME, Meltzer PC, Dutta AK.
    Eur J Pharmacol; 1994 Apr 15; 267(2):167-73. PubMed ID: 8050478
    [Abstract] [Full Text] [Related]

  • 2. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
    Dutta AK, Xu C, Reith ME.
    J Med Chem; 1998 Aug 13; 41(17):3293-7. PubMed ID: 9703474
    [Abstract] [Full Text] [Related]

  • 3. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
    Matecka D, Lewis D, Rothman RB, Dersch CM, Wojnicki FH, Glowa JR, DeVries AC, Pert A, Rice KC.
    J Med Chem; 1997 Feb 28; 40(5):705-16. PubMed ID: 9057857
    [Abstract] [Full Text] [Related]

  • 4. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus.
    Niznik HB, Fogel EF, Fassos FF, Seeman P.
    J Neurochem; 1991 Jan 28; 56(1):192-8. PubMed ID: 1987318
    [Abstract] [Full Text] [Related]

  • 5. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FH, Rice KC.
    J Med Chem; 1996 Nov 22; 39(24):4704-16. PubMed ID: 8941383
    [Abstract] [Full Text] [Related]

  • 6. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB, Cadet JL, Akunne HC, Silverthorn ML, Baumann MH, Carroll FI, Rice KC, de Costa BR, Partilla JS, Wang JB.
    J Pharmacol Exp Ther; 1994 Jul 22; 270(1):296-309. PubMed ID: 8035327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.
    Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC.
    J Med Chem; 2002 Sep 12; 45(19):4371-4. PubMed ID: 12213078
    [Abstract] [Full Text] [Related]

  • 9. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB, Ghorai SK, George C, Reith ME, Dutta AK.
    J Med Chem; 2003 May 22; 46(11):2205-15. PubMed ID: 12747792
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ, Neve RL, Janowsky A, Neve KA.
    J Pharmacol Exp Ther; 1995 Jul 22; 274(1):276-83. PubMed ID: 7616409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine.
    Hsin LW, Dersch CM, Baumann MH, Stafford D, Glowa JR, Rothman RB, Jacobson AE, Rice KC.
    J Med Chem; 2002 Mar 14; 45(6):1321-9. PubMed ID: 11882001
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.